Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-003897
Filing Date
2022-02-01
Accepted
2022-02-01 17:21:43
Documents
1
Period of Report
2022-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4115
  Complete submission text file 0000899243-22-003897.txt   5505
Mailing Address INDEVUS PHARMACEUTICALS, INC. 99 HAYDEN AVENUE LEXINGTON MA 02421
Business Address
Tucker John H (Reporting) CIK: 0001303480 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38293 | Film No.: 22580267

Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Issuer) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations